摘要
目的研究黑升麻提取物对人肝癌细胞系HepG2增殖和凋亡的影响。方法将肝癌HepG2细胞依据随机数字法分为黑升麻药物0、10、20、30、40、50μg/mL组,采用细胞计数试剂盒8检测实验组不同浓度(10、20、30、40、50μg/mL)黑升麻处理后HepG2细胞的增殖抑制率。流式细胞仪、Annexin V-异硫氰酸荧光素/碘化丙啶双染检测对照组(黑升麻药物浓度0μg/mL)及不同浓度(10、20、32μg/mL)黑升麻处理后实验组的HepG2凋亡细胞比率; Western blot检测凋亡相关胱天蛋白酶(caspase)-3、caspase-8、caspase-9蛋白的表达。结果 0、10、20、30、40、50μg/mL组抑制率分别为0%、(12. 51±9. 31)%、(27. 85±1. 51)%、(53. 20±5. 55)%、(67. 42±3. 54)%、(81. 43±0. 73)%,各组比较差异有统计学意义(P <0. 05),随着各组给药浓度的增加抑制率逐渐升高(P <0. 05)。黑升麻IC50为32. 010μg/mL。与0μg/mL组比较,10、20、32μg/mL组凋亡逐渐增加(P <0. 05),Cleaved caspase-3、Cleaved caspase-8蛋白表达上调(P <0. 05)。结论黑升麻提取物可有效抑制肝癌HepG2细胞系增殖,促进细胞凋亡,该作用至少部分依赖于外源性死亡受体途径。
Objective To explore the effect of black cohosh extracts on the proliferation and apoptosis of hepatocellular carcinoma HepG2 cells. Methods The HepG2 cells were divided into 0,10,20,30,40,50 μg/mL group.The inhibitory rate of proliferation of HepG2 cells in the experimental group treated with different concentrations of black cohosh (10,20,30,40,50 μg/mL) were analyzed by cell counting Kit-8 assay.The ratio of apoptotic cells in the blank control group and experimental group(10,20,32 μg/mL) was detected by Annexin V-fluoresceine isothiocyanate/propidium iodide double staining and flow cytometry.Expressions of apoptosis-related caspase-3,caspase-8 and caspase-9 proteins were detected by Western blot. Results The inhibitory rates of 0,10,20,30,40,50 μg/mL groups were 0%,(12.51±9.31)%,(27.85±1.51)%,(53.20±5.55)%,(67.42±3.54)% and (81.43±0.73)%,there was statistical significance in comparison among groups( P <0.05),and the inhibition rate gradually increased with the increase of drug concentration in each group( P <0.05).The IC 50 of black cohosh was 32.010 μg/mL. Compared with 0 μg/mL group,10,20,32 μg/mL group apoptosis increased gradually( P <0.05),expression of Cleaved caspase-3,Cleaved caspase-8 protein increased( P <0.05). Conclusion Black cohosh extract can effectively inhibit the proliferation of HepG2 cell lines and promote apoptosis,which is at least partially dependent on the exogenous death receptor pathway.
作者
倪璠
柯阳
邹仁超
艾润垚
马瑞成
周剑
郭志唐
王琳
NI Fan;KE Yang;ZOU Renchao;AI Runyao;MA Ruicheng;ZHOU Jian;GUO Zhitang;WANG Lin(Department of Hepatobiliary Surgery,the Second Affiliated Hospital of Kunming Medical University,Kunming 650101,China;Kunming Medical University,Kunming 650500,China)
出处
《医学综述》
2019年第5期1030-1035,共6页
Medical Recapitulate
基金
国家自然科学基金(81660399
81860423)
云南省创新团队计划(2015HC033)
云南省外国专家局项目(H162039011)
云南省卫生和计划生育委员会医学领军人才培养计划(L-201622)
昆明医科大学重大科技成果培育项目(CGPY201607)